Evidence map›Paper›PMID 33606150›Full record

ArticleMolecular biology reports2021

Nanomicellar curcuminoids attenuates renal ischemia/reperfusion injury in rat through prevention of apoptosis and downregulation of MAPKs pathways.

Zeinab Karimi, Roksana SoukhakLari, Khojasteh Rahimi-Jaberi, Zahra Esmaili, Maryam Moosavi

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zeinab KarimiShiraz Nephro-Urology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.
Roksana SoukhakLariShiraz Neuroscience Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.
Khojasteh Rahimi-JaberiShiraz Nephro-Urology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra EsmailiNanobiology and Nanomedicine Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam MoosaviNanobiology and Nanomedicine Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran. marmoosavi@sums.ac.ir.ORCID http://orcid.org/0000-0001-6943-477X
Shiraz University of Medical Sciences · IR

Funding

Vice-Chancellor for Research, Shiraz University of Medical Sciences 98-01-57-22109
6 · The paper itself

Abstract

Renal ischemia/reperfusion (I/R) injury is considered as a main problem in clinical practice. Curcuminoids, the active constituents of turmeric, seem to have potential renoprotective effects. However, the poor bioavailability of curcuminoids restricts their therapeutic effects. In the present study, the effect of nanomicellar curcuminoids (NC) treatment on renal function, histology, total antioxidant capacity (TAC), total oxidative stress (TOS), caspase-3 level as well as mitogen activated protein kinases (MAPKs: JNK, p38 and ERK) phosphorylation were evaluated following renal I/R. Adult male Sprague-Dawley rats were administered NC at the dose of 25 mg/kg 1 h before renal ischemia induction. The animals were subjected to bilateral renal ischemia for 60 min and reperfusion for 24 h. Subsequently, blood urea nitrogen (BUN), creatinine (Cr), renal histopathology, TAC, TOS, and oxidative stress index, cleaved caspase-3 level, Bax and MAPKs signaling were evaluated. The results indicated that NC pretreatment at the dose of 25 mg/kg significantly improved renal function as well as histolopatholgical damages. Moreover, NC reduced the level of renal oxidative stress, cleaved caspase-3 and Bax (as the proapoptotic proteins) and suppressed the activated Jun N-terminal Kinase (JNK), p38 and extracellular receptor kinase (ERK) signaling induced by renal I/R. The findings of the current study indicate that NC might prevent the injury induced by renal I/R through suppression of oxidative stress, apoptosis and MAPKs pathways.

Indexed as

AnimalsAntioxidantsApoptosisbcl-2-Associated X ProteinBlood Urea NitrogenCaspase 3CreatinineDiarylheptanoidsJNK Mitogen-Activated Protein KinasesKidneyMaleMAP Kinase Signaling SystemMitogen-Activated Protein KinasesNanoparticlesOxidative Stressp38 Mitogen-Activated Protein KinasesAntioxidantsbcl-2-Associated X ProteinCaspase 3CreatinineDiarylheptanoidsJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesCaspase-3Curcuminoid nanoparticleMAPKsOxidative stressRatRenal ischemia/reperfusion

Identifiers

PMID33606150
OpenAlexW3129712667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.